Abselion article published in International Biopharmaceutical Industry (IBI) Autumn 2025
We are pleased to announce that Abselion’s article has been published in the Autumn 2025 issue of International Biopharmaceutical Industry (IBI).
Co-authored by Professor Alan Dickson (University of Manchester) and Dr Paolo Romele (VP of Science, Abselion), the article explores how the Amperia™ platform enables practical, scalable protein quantification to support innovation in cell line development and biologics workflows.
Read the article on pages 48–52 of the IBI Autumn 2025 issue: here